Zhongnan Medical Journal Press

Home Results

A total of 121 result was found. Results that relate to System

Exploration of the application path of real-world evidence in the reform of China's pharmaceutical regulatory system: a case study of Hainan Boao Lecheng

Published on Chinese Journal of Pharmacoepidemiology 2026,35(3):346-354.
6052 times 1090 times

XIE Wansheng CAI Lixian LUO Wenya TONG Yeqing LIN Kai LI Zhongyang CHANG Limei ZHAO Tuo

Real-world evidence Real-world data Medical regulatory system Regulatory science
Details
A case of severe multisystem adverse reactions in a multiple myeloma patient following carfilzomib

Published on Chinese Journal of Pharmacoepidemiology 2026,35(3):355-360.
3551 times 841 times

CHENG Mei ZHAO Yun LIU Lili YAO Lijuan

Carfilzomib Multiple myeloma Adverse drug reactions Multisystem adverse reactions
Details
Role and related mechanisms of Porphyromonas gingivalis in the occurrence and development of digestive system tumors

Published on New Medicine 2026,36(3):342-347.
3271 times 915 times

LI Jingya SUN Jiachun KONG Jinyu GAO Shegan

Porphyromonas gingivalis Digestive system Tumor pathogenesis and progression Molecular mechanism
Details
Recent advances of non-viral vectors in DNA drug delivery field

Published on Frontiers in Pharmaceutical Sciences 2026,30(3):520-529.
4311 times 866 times

LIU Hanxiao YANG Xuehua LIU Zhengping MAO Kaifan XUE Song LI Dawei TANG Xuan

Non-viral vectors DNA drugs Delivery systems Targeted delivery Nanocarriers Biocompatibility Gene therapy Clinical translation
Details
Expert consensus for off-label drug use of rare diseases (2026 edition)

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):493-507.
3321 times 972 times

DUAN Yuehan CHEN Chaoyang ZHANG Yu CUI Yi-min WANG Shengfeng DING Jie Working Group of the Expert Consensus for Off-Label Drug Use of Rare Diseases

Rare disease Off-label drug use Expert consensus Thomson evidence grading system
Details
Correlation between the expression of cell proliferation nuclear antigen Ki-67 and tumor-infiltrating lymphocytes in breast cancer: a systematic review and Me-ta-analysis

Published on New Medicine 2026,36(5):559-566.
1507 times 462 times

LIU Fei LIU Tiebing GAO Siyu WANG Qi ZHANG Shilei LIU Jiangbo

Breast cancer Tumor-infiltrating lymphocytes Cell proliferation nuclear antigen Ki-67 Systematic review Meta-analysis
Details
Research progress on optimized technical paths of meloxicam dosage forms

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):876-884.
1647 times 383 times

YANG Jie YUAN Jing XU Shaohua LIAO Zongquan XIAO Gaofeng QU Longmei

Meloxicam Dosage form Drug delivery system Targeted preparations Sustained-release preparations Cyclooxygenase-2
Details
Efficacy and safety of galcanezumab in the treatment of migraine in adults: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):669-678.
1612 times 384 times

HE Xiaodong LI Qin KE Changhu LI Chunlei LIU Huimin

Galcanezumab Migraine Randomized controlled trial Systematic review Meta-analysis
Details
Current status and prospects of cardiovascular simulation medical education development

Published on New Medicine 2026,36(6):713-720.
1310 times 514 times

XUE Chuanwei QIN Peipei XIANG Jie WANG Fang

Medical simulation education Cardiology Modern medicine Training system
Details
Effects of soy isoflavones on serum lipid in patients with hyperlipidemia: a systematic review and Meta-analysis

Published on Journal of Mathematical Medicine 2026,39(7):506-515.
555 times 198 times

ZHANG Yihua WANG Xiumei JIA Yatian NIU Qingmei ZHANG Qian

Soy isoflavones Hyperlipidemia Blood lipid Systematic review Meta-analysis
Details
Research progress of mesenchymal stem cells in the treatment of reproductive system diseases

Published on Journal of Mathematical Medicine 2026,39(7):516-522.
544 times 181 times

LAN Lizhen FU Mingjun

Mesenchymal stem cells Reproductive system diseases Stem cell therapy Regenerative medicine
Details
PROBAST+AI: an interpretation of the tool for assessing the quality, risk of bias and applicability of prediction models based on traditional or artificial intelligence methods

Published on New Medicine 2026,36(7):721-733.
1543 times 206 times

ZOU Wenting ZHENG Qicheng HUANG Qiao WANG Yongbo REN Xiangying XIAO Shifeng JIN Yinghui YAN Siyu

PROBAST+AI Prediction model Systematic review Risk of bias Artificial intelligence Machine learning
Details
Mining and analysis of adverse event signals related to bosutinib based on the AEMS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1205-1212.
474 times 103 times

DI Panpan XING Xiaoqin LIANG Hai JIA Shuyun XIA Runan HU Yunfei

Bosutinib Adverse drug event Data mining Adverse Event Monitoring System database
Details
Identification of safety signals for antiepileptic drug-associated thrombocytopenia in minor population utilizing the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1196-1204.
496 times 115 times

DUAN Difan CHEN Yan LIN Gaoyang QIAN Mengying SHAN Qing GUO Jinmin

Thrombocytopenia Antiepileptic drugs Minor population Food and Drug Administration Adverse Event Reporting System Adverse drug event Signal mining
Details
Analysis of characteristics for SGLT2 inhibitor-associated Fournier gangrene based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(7):1223-1229.
466 times 110 times

TAN Wanli LI Dan YAO Huijuan

Sodium-glucose co-transporter 2 inhibitor Fournier gangrene Adverse drug reaction Data mining FDA Adverse Event Reporting System database
Details